Propranolol Suppresses Bladder Cancer by Manipulating Intracellular PH Via NHE1

Overview

Journal Transl Androl Urol

Date 2022 Sep 12

PMID 36092839

Authors

Qian Hu

Jiali Hu

Cuiyu Chen

Yang Wang

Yu Zhang

Jielin Wan

Ouyang Jing

Hanying Yi

Shiyu Wang

Weihua Huang

Jie Liu

Wei Zhang

Howard L McLeod

Ran Xu

Yijing He

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, a large number of clinical and epidemiological studies have revealed the anti-cancer activity of propranolol in solid tumors, though the underline mechanism is yet to be clarified.

Methods: The proliferation of bladder cancer cells treated with propranolol was detected by MTS assays. tumor xenograft experiments were used to observe the effect of propranolol on bladder cancer growth in mice. The expression levels of Na/H exchanger (NHE1) was measured by western blot. The frequency of CD8 T cells and CD4 T cells were detected via flow cytometry.

Results: In this study, propranolol inhibited the expression of NHE1 and sequentially led to a decrease of intracellular pH to 5.88 in MB49 cells and 6.85 in 5637 cells, thereafter, inhibited cell viability and induced apoptosis. Furthermore, propranolol inhibited the growth of bladder cancer in mice xenograft model. Flow cytometry found that the frequency of CD8 T cells (34.58±2.11 32.34±0.6, P=0.35) and CD4 T cells (57.80±2.45 51.44±0.79, P=0.06) in the spleen did not change compared with the control group, while the expression of IFN-γ, GZMB and T-bet secreted by CD8 T cells increased respectively (IFN-γ 7.3±0.17 3.37±0.58, P=0.0017; GZMB 16.66±2.13 4.53±0.62, P=0.0034; T-bet 3.62±0.35 1.74±0.26, P=0.0027). Meantime, the expression of FoxP3 on CD4 T cells decreased both in spleen and tumor tissue (1.53±0.11 0.91±0.1, P=0.004; 4.52±0.48 1.76±0.40, P=0.003).

Conclusions: These results suggested that propranolol exerted anti-proliferation and pro-apoptosis effects in bladder cancer cell by inhibiting Na/H exchange and activated systemic anti-tumor immune response .

Citing Articles

The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy.

Patwardhan M, Mahendran R Int J Mol Sci. 2023; 24(15).

PMID: 37569686 PMC: 10419109. DOI: 10.3390/ijms241512311.

The Prime and Integral Cause of Cancer in the Post-Warburg Era.

Harguindey S, Reshkin S, Alfarouk K Cancers (Basel). 2023; 15(2).

PMID: 36672490 PMC: 9856494. DOI: 10.3390/cancers15020540.

References

Rostamian H, Khakpoor-Koosheh M, Jafarzadeh L, Masoumi E, Fallah-Mehrjardi K, Tavassolifar M . Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions. BMC Cancer. 2022; 22(1):39. PMC: 8734242. DOI: 10.1186/s12885-021-09151-2. View

Cardone R, Casavola V, Reshkin S . The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer. 2005; 5(10):786-95. DOI: 10.1038/nrc1713. View

Liao X, Che X, Zhao W, Zhang D, Bi T, Wang G . The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling. Oncol Rep. 2010; 24(6):1669-76. DOI: 10.3892/or_00001032. View

Reshkin S, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M . Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000; 14(14):2185-97. DOI: 10.1096/fj.00-0029com. View

Lamboy-Caraballo R, Ortiz-Sanchez C, Acevedo-Santiago A, Matta J, Monteiro A, Armaiz-Pena G . Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells. Int J Mol Sci. 2020; 21(6). PMC: 7139728. DOI: 10.3390/ijms21062250. View

Flinck M, Kramer S, Pedersen S . Roles of pH in control of cell proliferation. Acta Physiol (Oxf). 2018; 223(3):e13068. DOI: 10.1111/apha.13068. View

Wang J, Choi S, Niu X, Kang N, Xue H, Killam J . Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity. Int J Mol Sci. 2020; 21(21). PMC: 7664620. DOI: 10.3390/ijms21218363. View

Zhou C, Chen X, Zeng W, Peng C, Huang G, Li X . Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway. Oncotarget. 2016; 7(42):68314-68327. PMC: 5356557. DOI: 10.18632/oncotarget.11599. View

Takatani-Nakase T, Matsui C, Hosotani M, Omura M, Takahashi K, Nakase I . Hypoxia enhances motility and EMT through the Na/H exchanger NHE-1 in MDA-MB-231 breast cancer cells. Exp Cell Res. 2022; 412(1):113006. DOI: 10.1016/j.yexcr.2021.113006. View

10.

Coelho M, Moz M, Correia G, Teixeira A, Medeiros R, Ribeiro L . Antiproliferative effects of β-blockers on human colorectal cancer cells. Oncol Rep. 2015; 33(5):2513-20. DOI: 10.3892/or.2015.3874. View

11.

He R, He Y, Tang Y, Zhou H, McLeod H, Liu J . The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference. Pharmacogenomics. 2015; 17(1):74-9. DOI: 10.2217/pgs.15.152. View

12.

Rotin D, Grinstein S, Tannock I . Requirement of the Na+/H+ exchanger for tumor growth. Cancer Res. 1989; 49(1):205-11. View

13.

Aronow W . Current role of beta-blockers in the treatment of hypertension. Expert Opin Pharmacother. 2010; 11(16):2599-607. DOI: 10.1517/14656566.2010.482561. View

14.

Nagoshi M, Goedegebuure P, Burger U, Sadanaga N, Chang M, Eberlein T . Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes. J Immunol. 1998; 160(1):334-44. View

15.

De Milito A, Canese R, Marino M, Borghi M, Iero M, Villa A . pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 2009; 127(1):207-19. DOI: 10.1002/ijc.25009. View

16.

Reshkin S, Cardone R, Harguindey S . Na+-H+ exchanger, pH regulation and cancer. Recent Pat Anticancer Drug Discov. 2012; 8(1):85-99. DOI: 10.2174/15748928130108. View

17.

Loo S, Chang M, Chua C, Kumar A, Pervaiz S, Clement M . NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des. 2012; 18(10):1372-82. DOI: 10.2174/138161212799504885. View

18.

Putney L, Denker S, Barber D . The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol. 2002; 42:527-52. DOI: 10.1146/annurev.pharmtox.42.092001.143801. View

19.

Montoya A, Varela-Ramirez A, Dickerson E, Pasquier E, Torabi A, Aguilera R . The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomed J. 2019; 42(3):155-165. PMC: 6717753. DOI: 10.1016/j.bj.2019.02.003. View

20.

Manu P, Rogozea L . Propranolol for Angina Pectoris. Am J Ther. 2016; 23(6):e1285-e1286. DOI: 10.1097/MJT.0000000000000528. View